#oncology

Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. ...

Early-stage ovarian cancer is usually discovered by chance, therefore, women need to remain alert about risk factors ...

Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early ...

RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today ...

Illumina, Inc., today announced, for the second consecutive year, Illumina is honored as one of Singapore’s Best ...

With a mission of empowering the rare disease community, Illumina has today partnered with medical researchers and ...

Regulatory News:     Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum ...

News Feature

Some people are fascinated by medical dramas because they are keen on observing how our bodies function, or ...

- On February 14th the melodious strains of the fourth movement of Mahler's Fifth Symphony were heard inside the ...

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its ...

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to ...

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

- Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief ...

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...